{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T02:32:50Z","timestamp":1773628370954,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,1,16]],"date-time":"2014-01-16T00:00:00Z","timestamp":1389830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s11033-014-3099-4","type":"journal-article","created":{"date-parts":[[2014,1,15]],"date-time":"2014-01-15T10:28:12Z","timestamp":1389781692000},"page":"2445-2452","source":"Crossref","is-referenced-by-count":2,"title":["Cloning, expression and purification of binding domains of lethal factor and protective antigen of Bacillus anthracis in Escherichia coli and evaluation of their related murine antibody"],"prefix":"10.1007","volume":"41","author":[{"given":"Mehdi","family":"Rezaee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Honari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza Ashrafi","family":"Kooshk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,16]]},"reference":[{"key":"3099_CR1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/414837a","volume":"414","author":"J Knight","year":"2001","unstructured":"Knight J (2001) Bioweapons: delivering death in the mail. Nature 414:837\u2013838","journal-title":"Nature"},{"key":"3099_CR2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0378-1119(89)90335-1","volume":"81","author":"TS Bragg","year":"1989","unstructured":"Bragg TS, Robertson DL (1989) Nucleotide sequence and analysis of the lethal factor gene (lef) from B. anthracis. Gene 81:45\u201354","journal-title":"Gene"},{"key":"3099_CR3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1365-2672.1999.00883.x","volume":"87","author":"R Okinaka","year":"1999","unstructured":"Okinaka R, Cloud K, Hampton O, Hoffmaster A, Hill K, Keim P, Koehler T, Lamke G, Kumano S, Manter D, Martinez Y, Ricke D, Svensson R, Jackson P (1999) Sequence assembly and analysis of pX01 and pX02. J Appl Microbiol 87:261\u2013262","journal-title":"J Appl Microbiol"},{"key":"3099_CR4","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1128\/IAI.45.3.761-767.1984","volume":"45","author":"JW Ezzell","year":"1984","unstructured":"Ezzell JW, Ivins BE, Leppla SH (1984) Immunoelectrophoretic analysis, toxicity and kinetics of in vitro production of the protective antigen and lethal factor components of B. anthracis toxin. Infect Immun 45:761\u2013767","journal-title":"Infect Immun"},{"key":"3099_CR5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/n35101998","volume":"414","author":"AD Pannifer","year":"2001","unstructured":"Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC (2001) Crystal structure of the anthrax lethal factor. Nature 414:229\u2013233","journal-title":"Nature"},{"key":"3099_CR6","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.addr.2005.01.028","volume":"57","author":"RN Brey","year":"2005","unstructured":"Brey RN (2005) Molecular basis for improved anthrax vaccines. Adv Drug Deliv Rev 57:1266\u20131292","journal-title":"Adv Drug Deliv Rev"},{"key":"3099_CR7","doi-asserted-by":"crossref","first-page":"6740","DOI":"10.1016\/j.vaccine.2010.07.075","volume":"28","author":"LW Baillie","year":"2010","unstructured":"Baillie LW, Huwar TB, Moore S, Mellado-Sanchez G, Rodriguez L, Neeson BN, Flick-Smith HC, Jenner DC, Atkins HS, Ingram RJ, Altmann DM, Nataro JP, Pasetti MF (2010) An anthrax subunit vaccine candidate based on protective region of B. anthracis protective antigen and lethal factor. Vaccine 28:6740\u20136748","journal-title":"Vaccine"},{"key":"3099_CR8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1086\/341902","volume":"35","author":"JG Bartlett","year":"2002","unstructured":"Bartlett JG, Inglesby TV Jr, Borio L (2002) Management of anthrax. Clin Infect Dis 35:851\u2013858","journal-title":"Clin Infect Dis"},{"key":"3099_CR9","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1016\/j.vaccine.2007.01.068","volume":"25","author":"JA Chichester","year":"2007","unstructured":"Chichester JA, Musiychuk K, de la Rosa P, Horsey A, Stevenson N, Ugulava N, Rabindran S, Palmer GA, Mett V, Yusibov V (2007) Immunogenicity of a subunit vaccine against B. anthracis. Vaccine 25:3111\u20133114","journal-title":"Vaccine"},{"key":"3099_CR10","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1128\/IAI.70.3.1653-1656.2002","volume":"70","author":"H Flick-Smith","year":"2002","unstructured":"Flick-Smith H, Walker N, Gibson P, Bullifent H, Hayward S, Miller J, Titball RW, Williamson ED (2002) A recombinant carboxyl-terminal domain of the protective 113 antigen of B. anthracis protects mice against anthrax infection. Infect Immun 70:1653\u20131656","journal-title":"Infect Immun"},{"key":"3099_CR11","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0092-8674(83)90402-6","volume":"34","author":"MH Vodkin","year":"1983","unstructured":"Vodkin MH, Leppla SH (1983) Cloning of the protective antigen gene of B. anthracis. Cell 34:693\u2013697","journal-title":"Cell"},{"key":"3099_CR12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0378-1119(88)90439-8","volume":"69","author":"SL Welkos","year":"1988","unstructured":"Welkos SL, Lowe JR, Eden-McCutchan F, Vodkin M, Leppla SH (1988) Sequence and analysis of the DNA encoding protective antigen of B. anthracis. Gene 69:287\u2013300","journal-title":"Gene"},{"key":"3099_CR13","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1128\/IAI.58.2.366-372.1990","volume":"58","author":"LC Iacono-Connors","year":"1990","unstructured":"Iacono-Connors LC, Schmaljohn CS, Dalrymple JM (1990) Expression of B. anthracis protective antigen by baculovirus and vaccinia virus recombinants. Infect Immun 58:366\u2013372","journal-title":"Infect Immun"},{"key":"3099_CR14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0006-291X(02)02625-6","volume":"299","author":"MA Aziz","year":"2002","unstructured":"Aziz MA, Singh S, Anand Kumar P, Bhatnagar R (2002) Expression of protective antigen in transgenic plants: a step towards edible vaccine against anthrax. Biochem Biophys Res Commun 299:345\u2013351","journal-title":"Biochem Biophys Res Commun"},{"key":"3099_CR15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.femsim.2005.05.008","volume":"45","author":"GE Rhie","year":"2005","unstructured":"Rhie GE, Park YM, Chun JH, Yoo CK, Seong WK, Oh HB (2005) Expression and secretion of the protective antigen of B. anthracis in B. brevis. FEMS Immunol Med Microbiol 45:331\u2013339","journal-title":"FEMS Immunol Med Microbiol"},{"key":"3099_CR16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-2672.1999.00900.x","volume":"87","author":"ND Zegers","year":"1999","unstructured":"Zegers ND, Kluter E, van Der Stap H, van Dura E, van Dalen P, Shaw M, Baillie L (1999) Expression of the protective antigen of B. anthracis by Lactobacillus casei: towards the development of an oral vaccine against anthrax. J Appl Microbiol 87:309\u2013314","journal-title":"J Appl Microbiol"},{"key":"3099_CR17","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/0264-410X(94)90148-1","volume":"12","author":"M Coulson","year":"1994","unstructured":"Coulson M, Fulop M, Tidball RW (1994) Bacillus anthracis protective antigen, expressed in Salmonella typhimurium SL 3261, affords protection against anthrax spore challenge. Vaccine 12:1395\u20131401","journal-title":"Vaccine"},{"key":"3099_CR18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pep.2004.08.007","volume":"38","author":"MW Laird","year":"2004","unstructured":"Laird MW, Zukauskas D, Johnson K, Sampey GC, Olsen H, Garcia A, Karwoski JD, Cooksey BA, Choi GH, Askins J, Tsai A, Pierre J, Gwinn W (2004) Production and purification of B. anthracis protective antigen from E. coli. Protein Expr Purif 38:145\u2013152","journal-title":"Protein Expr Purif"},{"key":"3099_CR19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1006\/prep.2000.1208","volume":"18","author":"S Park","year":"2000","unstructured":"Park S, Leppla SH (2000) Optimized production and purification of B. anthracis lethal factor. Protein Expr Purif 18:293\u2013302","journal-title":"Protein Expr Purif"},{"key":"3099_CR20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1006\/bbrc.2001.4777","volume":"283","author":"V Chauhan","year":"2001","unstructured":"Chauhan V, Singh A, Waheed SM, Singh S, Bhatnagar R (2001) Constitutive expression of protective antigen gene of B. anthracis in E. coli. Biochem Biophys Res Commun 283:308\u2013315","journal-title":"Biochem Biophys Res Commun"},{"key":"3099_CR21","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1046\/j.1365-2672.1998.00405.x","volume":"84","author":"L Baillie","year":"1998","unstructured":"Baillie L, Moir A, Manchee R (1998) The expression of the protective antigen of B. anthracis in B. subtilis. J Appl Microbiol 84:741\u2013746","journal-title":"J Appl Microbiol"},{"key":"3099_CR22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1046-5928(03)00132-3","volume":"30","author":"YM Kim","year":"2003","unstructured":"Kim YM, Koo BS, Chae YK, Yoon MY (2003) Production and proteolytic assay of lethal factor from B. anthracis. Protein Expr Purif 30:293\u2013300","journal-title":"Protein Expr Purif"},{"key":"3099_CR23","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1046-5928(02)00612-5","volume":"27","author":"S Krishnanchettiar","year":"2003","unstructured":"Krishnanchettiar S, Sen J, Caffrey M (2003) Expression and purification of the B. anthracis protective antigen domain 4. Protein Expr Purif 27:325\u2013330","journal-title":"Protein Expr Purif"},{"key":"3099_CR24","volume-title":"Molecular cloning laborator manual","author":"J Sambrook","year":"2001","unstructured":"Sambrook J, Russell DW (2001) Molecular cloning laborator manual. CSHL Press, New York"},{"key":"3099_CR25","volume-title":"Protein Methods","author":"DM Bollage","year":"1991","unstructured":"Bollage DM, Edelstein ST (1991) Protein Methods. Wiley, Switzerland"},{"key":"3099_CR26","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s11033-012-2144-4","volume":"40","author":"K Yari","year":"2013","unstructured":"Yari K, Afzali S, Mozafari H, Mansouri K, Mostafaie A (2013) Molecular cloning, expression and purification of recombinant soluble mouse endostatin as an anti-angiogenic protein in E.\u00a0coli. Mol Boil Rep 40:1027\u20131033","journal-title":"Mol Boil Rep"},{"key":"3099_CR27","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/S0264-410X(02)00172-X","volume":"20","author":"PR Pittman","year":"2002","unstructured":"Pittman PR (2002) Aluminum-containing vaccine associated adverse events: role of route of administration and gender. Vaccine 20:S48\u2013S50","journal-title":"Vaccine"},{"key":"3099_CR28","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.1016\/j.vaccine.2007.05.018","volume":"25","author":"MJ Hepburn","year":"2007","unstructured":"Hepburn MJ, Dyson HE, Simpson AJ, Brenneman KE, Bailey N, Wilkinson L, Hornby R, Mateczun AJ, Bell MG, Baillie LW (2007) Immune response to two different dosing schedules of the anthrax vaccine precipitated (AVP) vaccine. Vaccine 25:6089\u20136097","journal-title":"Vaccine"},{"key":"3099_CR29","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1128\/IAI.00261-07","volume":"75","author":"MT Albrecht","year":"2007","unstructured":"Albrecht MT, Li H, Williamson ED, LeButt CS, Flick-Smith HC, Quinn CP, Westra H, Galloway D, Mateczun A, Goldman S, Groen H, Baillie LW (2007) Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against B. anthracis infection and enhance endogenous immunity to anthrax. Infect Immun 75:5425\u20135433","journal-title":"Infect Immun"},{"key":"3099_CR30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1128\/IAI.00788-08","volume":"77","author":"ML Nguyen","year":"2009","unstructured":"Nguyen ML, Crowe SR, Kurella S, Teryzan S, Cao B, Ballard JD, James JA, Farris AD (2009) Sequential B-cell epitopes of B. anthracis lethal factor bind lethal toxin-neutralizing antibodies. Infect Immun 77:162\u2013169","journal-title":"Infect Immun"},{"key":"3099_CR31","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.1073\/pnas.1131930100","volume":"100","author":"N Kushner","year":"2003","unstructured":"Kushner N, Zhang D, Touzjian N, Essex M, Lieberman J, Lu Y (2003) A fragment of anthrax lethal factor delivers proteins to the cytosol without requiring protective antigen. PNAS 100:6652\u20136657","journal-title":"PNAS"},{"key":"3099_CR32","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1128\/JB.01493-06","volume":"189","author":"BY Hwang","year":"2007","unstructured":"Hwang BY, Varadarajan N, Li H, Rodriguez S, Iverson BL, Georgiou G (2007) Substrate specificity of the E. coli outer membrane protease OmpP. J Bacteriol 189:522\u2013530","journal-title":"J Bacteriol"},{"key":"3099_CR33","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1128\/IAI.65.12.5171-5175.1997","volume":"65","author":"SF Little","year":"1997","unstructured":"Little SF, Ivins BE, Fellows PF, Friedlander AM (1997) Passive protection by polyclonal antibodies against B. anthracis infection in guinea pigs. Infect Immun 65:5171\u20135175","journal-title":"Infect Immun"},{"key":"3099_CR34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.femsim.2004.05.011","volume":"42","author":"L Baillie","year":"2004","unstructured":"Baillie L, Townend T, Walker N, Erikson U, Williamson D (2004) Characterization of the human immune response to the UK anthrax vaccine. FEMS Immunol Med Microbial 42:267\u2013270","journal-title":"FEMS Immunol Med Microbial"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-014-3099-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-014-3099-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-014-3099-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T01:36:06Z","timestamp":1597368966000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-014-3099-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,16]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["3099"],"URL":"https:\/\/doi.org\/10.1007\/s11033-014-3099-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,16]]}}}